million or 20.03 % from the corresponding period of the previous year, mostly from revenue from UAC which increased Baht 80.22 million. 2. Other income increased Baht 25.02 million or 376.07% from the

Hospital Operations of Baht 200.01 million, a 43.68% increase year-over-year from Baht 139.21 million in 1Q18. This was mostly due to an increase in revenues from Inpatients, Outpatients and IVF patients

in 3Q17. This was mostly due to an increase in revenues from Inpatients, Outpatients and IVF patients. The Company reported Cost of Hospital Operations (including Depreciation and Amortization) of Baht

of Baht 638.12 million, a 22.02% improvement year-over-year from Baht 522.98 million in 2017. This was mostly due to an increase in revenues from Inpatients, Outpatients and opening of IVF Center. The

reported Revenues from hospital operations of Thai Baht 886.04 million, a 38.85% improvement year-over-year from Baht 638.12 million in 2018. This was mostly due to an increase in revenues from Inpatients

 200.01 million in 1Q19. This was mostly due to a decrease in revenues from  the epidemic of the coronary artery disease 2019 or Covid 19, affecting access to both inpatient and  outpatient services.  As

in 2Q18. This was mostly due to an increase in revenues from Inpatients, Outpatients and IVF patients. The Company reported Cost of Hospital Operations (including Depreciation and Amortization) of Baht

year-over-year from Baht 188.13 million in 3Q18. This was mostly due to an increase in revenues from Inpatients, Outpatients and IVF patients. The Company reported Cost of Hospital Operations (including

period of the previous year, mostly from revenue from UAC which increased Baht 346 million. 2. Gross profit was Baht 386.14 million which increased Baht 36.29 million or 10.37% from the corresponding

previous year as the following details below: 1. Revenue from sales and services increased Baht 926.03 million or 56.92 % from the corresponding period of the previous year, derived mostly from revenue from